Cleared Traditional

K231856 - TopFine® LDS (Low Dead Space) Syringe (2 models (TS-LDS2334, TS-LDS2534)) (FDA 510(k) Clearance)

Mar 2024
Decision
266d
Days
Class 2
Risk

K231856 is an FDA 510(k) clearance for the TopFine® LDS (Low Dead Space) Syringe (2 models (TS-LDS2334, TS-LDS2534)). This device is classified as a Low Dead Space Piston Syringe (Class II - Special Controls, product code QNQ).

Submitted by Medexel Co.,Ltd (Anseong, KR). The FDA issued a Cleared decision on March 15, 2024, 266 days after receiving the submission on June 23, 2023.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5860. A Low Dead Space Syringe Is A Piston Syringe Designed To Reduce Medication Waste. The Device Consists Of A Calibrated Hollow Barrel, A Moveable Plunger, And May Include A Needle. The Device Can Be Used By Health Care Professions Or For Self-injection By The Patient..

Submission Details

510(k) Number K231856 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2023
Decision Date March 15, 2024
Days to Decision 266 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code QNQ - Low Dead Space Piston Syringe
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860
Definition A Low Dead Space Syringe Is A Piston Syringe Designed To Reduce Medication Waste. The Device Consists Of A Calibrated Hollow Barrel, A Moveable Plunger, And May Include A Needle. The Device Can Be Used By Health Care Professions Or For Self-injection By The Patient.